Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Daniel D Shapiro

Showing results (51-60 of 69) with videos related to

Pageof 7
Sort By:
Cancers|February 10, 2024
Non-Metastatic Clear Cell Renal Cell Carcinoma Immune Cell Infiltration Heterogeneity and Prognostic Ability in Patients Following SurgeryDaniel D Shapiro, Taja Lozar, Lingxin Cheng, et al.
Urology|September 10, 2023
Contemporary Patients Have Better Perioperative Outcomes Following Cytoreductive Nephrectomy: A Multi-institutional Analysis of 1272 Consecutive PatientsAshanda R Esdaille, Jose A Karam, Viraj A Master, et al.
European Urology|December 6, 2020
Ductal Prostate Cancers Demonstrate Poor Outcomes with Conventional TherapiesWeranja Ranasinghe, Daniel D Shapiro, Hyunsoo Hwang, et al.
Cancers|January 28, 2026
Percutaneous Microwave Ablation Preserves Renal Function with Similar Long Term Oncologic Outcomes Compared to Surgery for Clinical T1 Renal Cell CarcinomaDaniel F Roadman, Daniel D Shapiro, Arighno Das, et al.
Urology|October 5, 2019
Comparing Outcomes for Patients with Clinical T1b Renal Cell Carcinoma Treated With Either Percutaneous Microwave Ablation or SurgeryDaniel D Shapiro, Shane A Wells, Sara L Best, et al.
Urology|February 5, 2026
A Simplified Prediction Tool for Metastasis after Nephrectomy with Venous Tumor Thrombectomy for RCCDaniel S Roberson, Spyridon P Basourakos, John C Cheville, et al.
Biorxiv : the Preprint Server for Biology|May 18, 2026
CXCL13-CXCR5 Signaling in CD8⁺ T Cell Recruitment and Lymphoid Immune Organization in Clear Cell Renal Cell CarcinomaDaniel D Shapiro, Kye D Nichols, Moon Hee Lee, et al.
The Journal of Urology|August 5, 2025
Risk Factors for First-Year Recurrence in Patients With Synchronous Metastatic Renal Cell Carcinoma Undergoing Cytoreductive Nephrectomy and Complete MetastasectomyAli Ghasemzadeh, E Jason Abel, Jose A Karam, et al.
Urology|December 13, 2025
Outcomes of Patients With Localized Renal Cell Carcinoma on Immunosuppression Following Solid Organ TransplantationParth V Shah, Edwin Jason Abel, Joshua D Mezrich, et al.
Clinical and Translational Medicine|May 25, 2023
Neddylation inhibition sensitises renal medullary carcinoma tumours to platinum chemotherapyDaniel D Shapiro, Niki Millward Zacharias, Durga N Tripathi, et al.
Pageof 7

Showing results (51-60 of 69) with videos related to

Sort By:
Pageof 7
Cancers|February 10, 2024
Non-Metastatic Clear Cell Renal Cell Carcinoma Immune Cell Infiltration Heterogeneity and Prognostic Ability in Patients Following SurgeryDaniel D Shapiro, Taja Lozar, Lingxin Cheng, et al.
Urology|September 10, 2023
Contemporary Patients Have Better Perioperative Outcomes Following Cytoreductive Nephrectomy: A Multi-institutional Analysis of 1272 Consecutive PatientsAshanda R Esdaille, Jose A Karam, Viraj A Master, et al.
European Urology|December 6, 2020
Ductal Prostate Cancers Demonstrate Poor Outcomes with Conventional TherapiesWeranja Ranasinghe, Daniel D Shapiro, Hyunsoo Hwang, et al.
Cancers|January 28, 2026
Percutaneous Microwave Ablation Preserves Renal Function with Similar Long Term Oncologic Outcomes Compared to Surgery for Clinical T1 Renal Cell CarcinomaDaniel F Roadman, Daniel D Shapiro, Arighno Das, et al.
Urology|October 5, 2019
Comparing Outcomes for Patients with Clinical T1b Renal Cell Carcinoma Treated With Either Percutaneous Microwave Ablation or SurgeryDaniel D Shapiro, Shane A Wells, Sara L Best, et al.
Urology|February 5, 2026
A Simplified Prediction Tool for Metastasis after Nephrectomy with Venous Tumor Thrombectomy for RCCDaniel S Roberson, Spyridon P Basourakos, John C Cheville, et al.
Biorxiv : the Preprint Server for Biology|May 18, 2026
CXCL13-CXCR5 Signaling in CD8⁺ T Cell Recruitment and Lymphoid Immune Organization in Clear Cell Renal Cell CarcinomaDaniel D Shapiro, Kye D Nichols, Moon Hee Lee, et al.
The Journal of Urology|August 5, 2025
Risk Factors for First-Year Recurrence in Patients With Synchronous Metastatic Renal Cell Carcinoma Undergoing Cytoreductive Nephrectomy and Complete MetastasectomyAli Ghasemzadeh, E Jason Abel, Jose A Karam, et al.
Urology|December 13, 2025
Outcomes of Patients With Localized Renal Cell Carcinoma on Immunosuppression Following Solid Organ TransplantationParth V Shah, Edwin Jason Abel, Joshua D Mezrich, et al.
Clinical and Translational Medicine|May 25, 2023
Neddylation inhibition sensitises renal medullary carcinoma tumours to platinum chemotherapyDaniel D Shapiro, Niki Millward Zacharias, Durga N Tripathi, et al.
Pageof 7